Sandra Heskamp

28PUBLICATIONS
96CO-AUTHORS
AcceleratorsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Supramolecular chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 15, 2026
Predicting tumour and organ dose in α-radiopharmaceutical therapy: a <sup>89</sup>Zr-based dosimetric approach for <sup>225</sup>Ac.

|May 11, 2026
Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8<sup>+</sup> T-cell infiltration.

|Mar 25, 2026
In-vivo analysis of neuroblastoma targeting potential of aGD2-SIRPα fusion antibodies for local CD47 blockade.

Fabian Schuurmans, Matthia G M Boros, Renske J E van den Bijgaart

|May 09, 2025
Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity.

Eva Peeters, Evelien A J van Genugten, Sandra Heskamp

|Apr 25, 2025
Efficacy of combined targeted radionuclide therapy and immune checkpoint Inhibition in animal tumour models: a systematic review and meta-analysis of the literature.

Simone C Kleinendorst, Carlijn R Hooijmans, Stijn Muselaers

|Apr 09, 2025
Site-directed multivalent conjugation of antibodies to ubiquitinated payloads.

Angela F El Hebieshy, Zacharias Wijfjes, Camille M Le Gall

Pageof 5

Frequent Collaborators

5 joint publications

Johan Bussink

4 joint publications

Erik H J G Aarntzen

3 joint publications

Gosse J Adema

3 joint publications

Martijn Verdoes